Lesión anular en un paciente expuesto a zonas montañosas: diagnóstico y comentario

• Aina Estany-Bécares ^[1] ; Pablo Castro García ^[1] ; Berta Ferrer Fábrega ^[1] ; Carla Ferrándiz-Pulido ^[1]
  1. [1] Hospital Vall d'Hebron

     Hospital Vall d'Hebron

     Barcelona, España

     
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 41, Nº. 4 (Abril), 2026, págs. 354-356
• Idioma: español
• DOI: 10.1016/j.piel.2026.02.002
• Títulos paralelos:
  • Annular lesion in a patient exposed to mounainous areas: Diagnosis and comment
• Texto completo no disponible (Saber más ...)
• Referencias bibliográficas
  • Bolognia JL, Schaffer JV, Cerroni L. Dermatol. 4th ed. Elsevier; 2018.
  • Wright W, Riedel D, Talwani R, Gilliam B. Diagnosis and management of Lyme disease. Am Fam Physician. 2012;85(11): 1086–1093.
  • Lantos P, Rumbaugh J, Bockenstedt L, et al. IDSA-AAN-ACR Lyme disease guidelines. Clin Infect Dis. 2021;72(1):1–8.
  • Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461–473.
  • Moore A, Nelson C, Molins C, Mead P, Schriefer M. Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis...
  • Steere AC, McHugh G, Damle N, Sikand V. Prospective study of serologic tests for Lyme disease. Clin Infect Dis. 2008;46: 188–195.
  • Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to...
  • Hilton E, DeVoti J, Benach JL, Halluska ML, White DJ, Paxton H. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population...
  • Murray T, Shapiro E. Lyme disease. Clin Lab Med. 2010;30(1): 311–328.
  • Fallon BA, Pavlicova M, Coffino SW, Brenner C. A comparison of Lyme disease serologic test results from 4 laboratories in patients with persistent...